Armephaco Joint Stock Co
UUPCOM:AMP14,300.00
VND
-200.00
(-1.38%)
ISIN
VN000000AMP7
Return %
Stock
S&P 500
1Y
10.00
14.20
3Y
-27.78
81.12
5Y
-16.86
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Ha Noi Vietnam
- IPO Date
- Jan 12, 2017
- Website
- armephaco.com.vn
- Similar Companies
- Business
- Armephaco Joint Stock Company is a Vietnam-based healthcare and pharmaceutical enterprise primarily engaged in the manufacturing, importation, distribution, and installation of pharmaceuticals, medical devices, and specialized hospital engineering systems. Founded in 1996 and headquartered in Hanoi, Vietnam, the company operates across three core business segments: Pharmaceutical Manufacturing and Trading, Medical Equipment and Consumables, and Healthcare Technical Engineering. Its product and service portfolio includes the development and production of generic prescription medications, over-the-counter formulations, traditional herbal medicines, and dietary supplements spanning therapeutic categories such as antibiotics, analgesics, anti-inflammatory agents, cardiovascular treatments, respiratory remedies, and multivitamin complexes; the manufacture, importation, and supply of medical apparatus, including surgical instruments, dental treatment units, diagnostic imaging systems, laboratory diagnostic analyzers, patient monitoring systems, autoclave sterilizers, hospital beds, and clinical examination furniture; and the delivery of specialized medical engineering solutions, encompassing the turnkey design, construction, installation, calibration, and maintenance of centralized medical gas piping networks, modular cleanrooms, operating theater environments, and hospital wastewater and biohazard treatment systems. Armephaco supplies both military and civilian healthcare facilities, including public provincial and national general hospitals, private medical centers, specialty clinics, research institutes, and commercial pharmacy networks throughout Vietnam, while maintaining export partnerships in Southeast Asia. In recent operational and strategic developments, the company has advanced the technical modernization of its WHO-GMP and ISO-certified manufacturing facilities, expanded its turnkey healthcare infrastructure contracting division to support major hospital expansion and renovation initiatives across Vietnam, broadened strategic distribution agreements with international medical device manufacturers to supply advanced diagnostic and critical care technologies, and enhanced its logistics and cold-chain distribution network to optimize commercial pharmaceutical delivery nationwide.